全球聽力學設備市場 - 2023-2030
市場調查報告書
商品編碼
1373381

全球聽力學設備市場 - 2023-2030

Global Audiology Devices Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

由於從大腦到耳朵的神經通路的改變,老年人更容易出現聽力損失。聽力學設備用於檢測和治療聽力損失或異常。聽力學設備通常稱為助聽器,用於監測和研究人們的聽力問題。

助聽器、人工耳蝸和骨錨式聽覺植入物都可以幫助聽力損失患者。助聽器使用內建麥克風、擴大機和揚聲器來放大聲音。這些是聲音放大設備,旨在幫助有聽力障礙的人。

市場動態:促進因素與限制因素

設備啟動數量增加

由於先進設備能夠提供高效的聽力解決方案,預計其數量的增加將推動市場成長。

例如,2023 年 9 月 25 日,人工智慧助聽器和音訊解決方案供應商 ELEHEAR 推出了首款 OTC 助聽設備,包括 ELEHEAR Alpha 和 ELEHEAR Alpha Pro。

2023 年 8 月 7 日,Unitron 推出了 Moxi V-RS,這是一款新型可充電聽力設備,該設備在該公司最近推出的 Vivante 平台上運行。

此外,2022 年 10 月 17 日,Lexie Hearing 推出了由 Bose 支援的 Lexie B2 助聽器,為其聽力學家品質的助聽器產品套件添加了第三種助聽器型號。此外,聽力損失患者數量的增加以及產品技術的進步也推動了市場的成長。

克制

與設備相關的高成本

在沒有保險的情況下,人工耳蝸的平均費用為 30,000 美元至 50,000 美元。因此,由於成本高昂,大多數人買不起這些設備,這可能會阻礙市場成長。

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 技術片段
  • 按產品類型分類
  • 按指示顯示的片段
  • 按配銷通路分類
  • 按地區分類

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 設備啟動數量增加
      • YY
    • 限制
      • 與設備相關的高成本
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按技術

  • 數位的
  • 模擬

第 8 章:依產品類型

  • 助聽器
  • 人工耳蝸
  • 骨傳導裝置
  • 診斷設備

第 9 章:依指示

  • 耳硬化症
  • 梅尼爾氏症
  • 聲學腫瘤
  • 中耳炎
  • 其他

第 10 章:按配銷通路

  • 零售銷售
  • 網路商店
  • 政府採購
  • 電子商務
  • 其他

第 11 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章:公司簡介

  • Oticon Medical
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Med-EL
  • Starkey Hearing Technologies
  • Phonak
  • Advanced Bionics
  • Audina Hearing Instruments, Inc.
  • Coselgi
  • Sonova AG
  • WS Audiology A/S
  • BHM-Tech Produktionsgesellschaft mbH

第 14 章:附錄

簡介目錄
Product Code: MD1661

Overview

Hearing loss is more likely in elderly people due to alterations in the neurological route from the brain to the ear. Audiology devices are used to detect and treat hearing loss or abnormalities. Audiology devices are commonly known as hearing aids and are used to monitor and study hearing issues in people.

Hearing aids, cochlear implants, and bone-anchored auditory implants all help people with hearing loss. A hearing aid amplifies sound using a built-in microphone, amplifier, and speaker. These are sound-amplifying devices designed to aid people who have a hearing impairment.

Market Dynamics: Drivers & Restraints

Increase in the number of device launches

The increase in the number of highly advanced device launches is expected to drive market growth due to their ability to provide hearing solutions with high efficiency.

For instance, on September 25, 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices, these include the ELEHEAR Alpha and ELEHEAR Alpha Pro.

On August 7, 2023, Unitron launched Moxi V-RS, a new rechargeable hearing device, that operates on the company's recently launched Vivante platform.

Additionally, on October 17, 2022, Lexie Hearing launched the Lexie B2 Hearing Aids, Powered by Bose, adding a third hearing aid model to its suite of audiologist-quality hearing aid products. Furthermore, the increase in the number of patients with hearing loss, and technological advancements of the products also drive the market growth.

Restraint

High costs associated with the devices

The average cost of cochlear implants can range from $30,000 to $50,000 without insurance. Thus, most people cannot afford the devices due to their high cost, which can hamper the market growth.

Segment Analysis

The global audiology devices market is segmented based on technology, product type, indication, distribution channel and region.

Cochlear implants segment accounted for 56.3% of the market share

Cochlear implants segment has been holding a significant position in the market share. Cochlear implants are electronic devices that improve hearing in people who have severe hearing loss due to damage to the inner ear. The increase in the launches of advanced cochlear devices is expected to drive the growth of the segment.

For instance on August 18, 2023, Cochlear Limited, introduced its next-generation Cochlear Osia System with the ability to have an MRI at 3.0 T, designed to improve hearing outcomes for people with conductive hearing loss.

For instance, in August 2021, Cochlear Limited launched the Nucleus Kanso 2 Sound Processor in Singapore. The new launch reflects Cochlear's ongoing commitment to innovation in hearing technology to provide amplified access to smartphone connectivity and help to improve hearing performance in people with hearing loss. Thus, the increased launches of advanced products that help with hearing are expected to drive the segment growth.

Geographical Analysis

North America is expected to hold a significant position in the global audiology devices market share

North America has been a dominant force in the audiology devices market owing to the increase in the number of hearing issues. The increase in the aged population and the presence of a number of medical device manufacturers in the region also act as the driving factors of the market growth in the region. It is expected to continue throughout the forecast period.

For instance, according to the report published by the National Council on Aging, Inc. in 2023, it is estimated that 48 million Americans currently experience hearing loss to some degree. The number of Americans with hearing loss is expected to increase by 30 million in the next four decades.

Additionally, according to the article published by the National Institute of Health in March 2022, Otosclerosis affects more than three million Americans. Many cases of otosclerosis are thought to be inherited. Otosclerosis is a condition in which the bones inside the ear cause gradual hearing loss. Thus, increase in the number of cases with hearing loss increases the demand for the audiology devices, which is expected to drive the market growth.

COVID-19 Impact Analysis:

The pandemic has significantly impacted the global audiology device market. Patients with routine consultation and follow-up care were interrupted due to hospitals delivering only emergency services. Therefore, many patients were neglected from hearing disorder treatment as it is considered as a non-emergency treatment. Thus, COVID-19 has impacted negatively on the market growth.

Competitive Landscape

The leading companies with a significant market share include: Oticon Medical, Med-EL, Starkey Hearing Technologies, Phonak, Advanced Bionics, Audina Hearing Instruments, Inc., Coselgi, Sonova AG, WS Audiology A/S, and BHM-Tech Produktionsgesellschaft mbH among others.

Key Developments

  • On August 29, 2023, Lucid Hearing launched its Tala over-the-counter (OTC) hearing aid product line. Texas-based Lucid Hearing designed Tala with Bluetooth-compatible wireless streaming.
  • On June 21, 2023, Sonova launched its first OTC hearing aid with an "In-Clinic Care Package" Option.
  • On November 1, 2022, Cochlear Limited received the U.S. Food and Drug Administration (FDA) approval for the CochlearTM Nucleus 8 Sound Processor.

Why Purchase the Report?

  • To visualize the global audiology devices market segmentation based on technology, product type, indication, distribution channel and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of audiology devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global audiology devices market report would provide approximately 69 tables, 71 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by Indication
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of device launches
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with the devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Digital *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Analog

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Hearing Aids *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cochlear Implants
  • 8.4. Bone Conduction Devices
  • 8.5. Diagnostic Devices

9. By Indication

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 9.1.2. Market Attractiveness Index, By Indication
  • 9.2. Otosclerosis *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Meniere's Disease
  • 9.4. Acoustic Tumors
  • 9.5. Otitis Media
  • 9.6. Others

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Retail Sales *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Online Stores
  • 10.4. Government Purchases
  • 10.5. E-Commerce
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Oticon Medical *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Med-EL
  • 13.3. Starkey Hearing Technologies
  • 13.4. Phonak
  • 13.5. Advanced Bionics
  • 13.6. Audina Hearing Instruments, Inc.
  • 13.7. Coselgi
  • 13.8. Sonova AG
  • 13.9. WS Audiology A/S
  • 13.10. BHM-Tech Produktionsgesellschaft mbH

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us